Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
about
Choline Metabolism Alteration: A Focus on Ovarian CancerSystems biology of cisplatin resistance: past, present and futureIdentification of cisplatin-regulated metabolic pathways in pluripotent stem cellsCombined Gene Expression and RNAi Screening to Identify Alkylation Damage Survival Pathways from Fly to HumanThe Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian CancerNRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cellsCytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties.MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells.Protective effect of Glycine max and Chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death.CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells.p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells.A metabolomic approach to identifying platinum resistance in ovarian cancer.p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cellsGlobal metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinomaPredictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapyRole of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer.Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian CancerHospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line.Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells.Increased breast cancer cell toxicity by palladination of the polyamine analogue N (1),N (11)-bis(ethyl)norspermine.Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice.Anticancer activity of metal complexes: involvement of redox processes.Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing.Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell LinesOverexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy.In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes.Alterations of phosphoproteins in NCI-H526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene Y.Intracellular GSH Alterations and Its Relationship to Level of Resistance following Exposure to Cisplatin in Cancer Cells.VSV based virotherapy in ovarian cancer: the past, the present and …future?Redox-dependent modulation of metformin contributes to enhanced sensitivity of esophageal squamous cell carcinoma to cisplatin.Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.Identification of Wild Yeast Strains and Analysis of Their β-Glucan and Glutathione Levels for Use in Makgeolli Brewing.Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
P2860
Q26742116-6D4C18D7-5347-4EF0-A5D2-9474108BE230Q26863585-A63416A8-DC78-4886-9794-043F4EEEC3A6Q28534469-7A2D422F-1B47-4C4D-AC1B-4F212E05686EQ28551514-C2081DFF-8999-4528-B7BF-4DAFDA7FCE99Q28833833-C0B9F942-E390-43C1-AE0C-77E7939D1BE8Q29247923-572E156A-790E-4E89-B58D-38A6796E540EQ33696556-76C65B77-F644-4203-A497-124BFE1EC983Q33808084-8B63B2F1-A4B6-4A19-A176-327AA5FA7B57Q33846828-73EFEBBC-CF54-472A-8966-FDA9B3529EB8Q34170564-BA52D198-4EB7-44CA-A6B1-D2EA86B42B47Q34208237-B88D0ED9-E565-4843-B867-BFB5AE5A4D60Q34456644-47239364-645F-4CF4-8EB8-BF35A1C2F7AFQ35404082-006F9871-1E1D-4F01-BC1A-7080CD1E588DQ35551953-5A5E0471-1329-490F-9330-640083A52D1AQ35667409-AB6CD01E-F03B-4FA7-BB98-CD264ABD5E3EQ35793767-7D1F1BB3-BABE-43D6-9101-D6885AA0605CQ35869320-F176B3BB-F979-4A09-BA1B-2CE127D0DA25Q36243650-8FCD6F9A-E776-40FD-873E-BA94753679AAQ36291188-AF6F2DE9-9210-4885-BD25-AA00E15B5421Q36844694-54FCA622-D084-4823-8381-3C7FDEA94166Q36922131-28A13229-8EC4-4D63-9B76-D9CC5220BE86Q37209426-2D0C2CF3-AF83-49F2-92D3-111C38B0CCC5Q37226453-009E71A8-320A-46C6-9FB1-2C4035A474F8Q37530925-BF9E365A-1B02-401D-9570-3C20898A8B02Q37682756-3CB22FC5-20CC-4E22-921C-B260CDFEB6B0Q37734911-F1E53DCF-48FA-4B08-8907-30B9EEABAA4DQ37833099-99FA7E09-48B2-4E1C-A0F7-640D6EC6A0F0Q38186660-AE262D83-E4A9-4243-B76B-C1FD3D620EF5Q38647100-94059D20-80F2-4812-B990-79374233A6C3Q38806337-5542B48B-8F71-4EB0-A9C7-66BDF555F697Q38823110-9138D91D-4369-4924-8FDC-7D0FFE5BF435Q38838936-14C5ACB0-9287-4740-ADB4-7F309A48E533Q39247606-B61478A2-23D8-486C-90AA-EFD20E93448CQ39270001-00106ABC-B6CA-4891-988B-F5F6ACBDA30BQ39785887-4EDB53E6-3315-4294-BA0D-87F3CD183408Q41441101-6836A4B9-38E9-4A6C-9075-8DB297AD7540Q42365321-12BE6592-5EE1-43DF-9445-7083792DDFC8Q42571058-045268B1-0AE0-46EF-9E60-69890BAA7ADDQ43110926-C7F8BF2C-B43B-43F7-88EB-2FBCCD0D9DA6Q46499332-FEF8C9BA-0BA7-4C80-BCEB-D64FD58A51E0
P2860
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@ast
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@en
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@nl
type
label
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@ast
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@en
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@nl
prefLabel
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@ast
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@en
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@nl
P2860
P356
P1433
P1476
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
@en
P2093
Helen H W Chen
Macus Tien Kuo
P2860
P356
10.1155/2010/430939
P577
2010-09-14T00:00:00Z